Developer docs
API playgroundTry for free, no card

Search company profiles

NeoLight

Full company profile

uuid0002k3p

Namestring
NeoLight
Legal namestring
NeoLight LLC
Websiteurl
theneolight.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

NeoLight is a Scottsdale, Arizona-based medical device company founded in 2014 that develops a portfolio of neonatal care technologies organized across five product categories: ocular screening (Phoenix ICON, Phoenix ICON GO, and Phoenix CONNECT telemedicine platform), jaundice treatment (Skylife phototherapy system), brain monitoring (néo CFM with aEEG), non-nutritive sucking therapy (P.A.L. Pacifier Activated Lullaby), and neonatal transport/thermoregulation (NEOPOD, BABYPOD series, SCANPOD, BP37). Core technologies include patented Direct Illumination retinal imaging, Skylife's 3D Light Array providing 40% body surface coverage, and the Phoenix CONNECT cloud-based telemedicine platform that connects nursing, ophthalmology, and neonatology teams for remote expert screening.

The company serves hospitals, NICUs, ophthalmology departments, and home healthcare settings, with claimed reach into 90% of America's top children's hospitals and distribution in more than 95 countries. Its go-to-market combines direct enterprise sales in the US and Canada with GPO contracts (Vizient, Capstone Health Alliance, Premier KIINDO) for hospital network access and international distribution partners for global markets. Revenue is generated through capital medical device hardware sales, with the Phoenix CONNECT platform providing potential recurring software revenue. Strategic acquisitions have been central to portfolio expansion, including Phoenix Technology Group (Nov 2021) for ophthalmic imaging and P.A.L. musical pacifier technology (Oct 2022), with an announced agreement to acquire InterVIEW Medical Systems (April 2023).

NeoLight has raised approximately $18.4 million across eight funding rounds from 2015-2022, with the largest disclosed round being $7 million in August 2020 from Dignity Health, Honor Health, and the Roethlisberger family. The company holds multiple FDA 510(k) clearances and issued US patents, and is led by co-founder and CEO Vivek Kopparthi alongside a management team including CCO MaryBeth Smith, CFO Ronald Wysochansky, and co-founder Deepak Krishnaraju, with a board that includes former Stryker executive Jim Heath and other medical device veterans.

Short descriptiontext

NeoLight is a Scottsdale-based medical device company developing neonatal care technologies including phototherapy (Skylife), retinal imaging (Phoenix ICON), brain monitoring (néo CFM), and transport devices, serving hospitals, NICUs, and home healthcare markets across 95+ countries.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersScottsdale, United States
HQ citystring
Scottsdale
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
neonatal medical devices, phototherapy systems, retinal imaging devices, brain monitoring equipment, neonatal transport equipment
Industry1 code
PRIMARYHLACAFAC
Maternal & Neonatal Remote Monitoring Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Neonatal Medical Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Hardware Sales
TypeHardware Sales
Description

NeoLight generates revenue through the sale of capital medical equipment including Skylife Neonatal Phototherapy System, Phoenix ICON ophthalmic imaging systems, nëo CFM brain monitoring devices, and P.A.L. non-nutritive sucking devices. Products are sold to hospitals, clinics, and healthcare providers for neonatal care.

theneolight.com
2Phoenix CONNECT Software Platform
TypeSubscription Recurring
Description

Cloud-based telemedicine platform for ophthalmic screening is offered as part of the product ecosystem, potentially generating recurring revenue through software subscriptions and services.

theneolight.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

NeoLight designs, manufactures, and sells a portfolio of proprietary neonatal medical devices for hospitals and NICUs, organized across ocular screening (Phoenix ICON retinal imaging systems and Phoenix CONNECT telemedicine platform), jaundice care (Skylife phototherapy), brain monitoring (nëo CFM aEEG), non-nutritive sucking therapy (P.A.L.), and neonatal transport (NEOPOD, BABYPOD series, SCANPOD, BP37). The company sells capital equipment through direct sales in the US/Canada and via international distribution partners across 95+ countries, supplemented by GPO contracts and recurring software subscriptions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 40% body surface coverage with Skylife 3D Light Array
+4 more records
Product overview1 text field

NeoLight is a medical device company offering a portfolio of empathy-driven neonatal care technologies organized across five product categories: (1) Ocular Screening via the Phoenix ICON platform family (Phoenix ICON desktop retinal imaging, Phoenix ICON GO portable imaging, and Phoenix CONNECT telemedicine platform); (2) Jaundice Care through the Skylife Neonatal Phototherapy System with best-in-class spectral power; (3) Brain Monitoring via the nëo CFM aEEG system; (4) Non-Nutritive Sucking through P.A.L. technology; and (5) Neonatal Transport including NEOPOD, BABYPOD series, SCANPOD, and BP37 thermal accessories. The company operates a platform-plus-products architecture, with Phoenix CONNECT serving as a cloud-based telemedicine hub connecting the various imaging and screening products across hospital networks.

Product and service12 records
1Phoenix ICON
CategoryOcular Screening / Retinal Imaging
Description

Retinal imaging system with patented Direct Illumination technology delivering superior high-resolution, high-contrast imaging on both light and dark retinas; sold direct in US/Canada and via distribution partners in 95+ countries for neonatal and pediatric ophthalmic screening.

2Phoenix ICON GO
CategoryOcular Screening / Portable Retinal Imaging
Description

Lightweight, portable retinal imaging system capable of supporting large remote networks and inter-hospital subspecialties; FDA 510(k) cleared with expanded fluorescein angiography capabilities for neonatal and pediatric use.

3Phoenix CONNECT
CategoryTelemedicine Software Platform
Description

Cloud-based telemedicine communication platform for retinal imaging programs that connects nursing, ophthalmology, and neonatology teams to enable timely expert screening of babies in any NICU.

4Skylife Neonatal Phototherapy System
CategoryJaundice Care / Phototherapy
Description

Neonatal Phototherapy System with best-in-class spectral power and 3D Light Array providing 40% body surface coverage with effective, uniform light; FDA cleared for hospital and home use to treat hyperbilirubinemia.

5nëo CFM Brain Monitoring System
CategoryBrain Monitoring / EEG
Description

Advanced brain monitoring system with aEEG (amplitude-integrated electroencephalography) for accelerated decision-making during neonatal care; exclusive USA partnership with ANT Neuro.

6P.A.L. (Pacifier Activated Lullaby)
CategoryNon-Nutritive Sucking Therapy
Description

Therapeutic system that encourages and reinforces effective non-nutritive sucking of premature infants through positive audio feedback using parents' voices to promote progression of oral feeding.

7NEOPOD
CategoryNeonatal Transport
Description

Safe, secure newborn baby transport system for neonatal and pediatric transport.

8BABYPOD 2
CategoryNeonatal Transport
Description

Infant transport device designed for safe neonatal transport with thermal regulation features.

9BABYPOD 20
CategoryNeonatal Transport
Description

Next-generation infant transport device with design advances for improved neonatal transport safety and functionality.

10SCANPOD
CategoryNeonatal Transport / Imaging-Compatible
Description

Specialized transport pod designed for MRI, CT, or X-Ray imaging of infants.

11BP37 Thermal Support Kit
CategoryNeonatal Thermoregulation Accessory
Description

Infant temperature maintenance kit providing thermal support accessory for Babypod transport systems.

12P.A.L. Music Service
CategoryNon-Nutritive Sucking Service
Description

Service that empowers neonatal care with the sound of parents' voices, extending the P.A.L. therapeutic platform.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-01-28
Description

Strategic partnership for continued expansion of the neonatal ecosystem, announced January 2026.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-11-27
Description

KIINDO breakthrough technology agreement providing Premier members access to NeoLight's Skylife systems. Premier is the nation's largest member-driven healthcare performance improvement company.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-07-08
Description

Exclusive USA partnership for the nëo CFM brain monitoring system. ANT Neuro provides EEG/aEEG technology expertise while NeoLight distributes and commercializes the system in the US market.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-02-01
Description

GPO contract with Capstone Health Alliance for Skylife Neonatal Phototherapy System, providing access to member hospitals.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-09-26
Description

Partnership with Florida State University's National Institute for Infant and Child Medical Music Therapy to extend P.A.L. technology application. FSU provides research and clinical expertise in music therapy for premature infants while NeoLight provides the technological platform.

6InterVIEW Medical Systems
Strategic tierMinorTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2023-04-25
Description

Agreement to acquire InterVIEW Medical Systems, a globally recognized provider of ROP education and examination content.

theneolight.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-09-06
Description

Innovative Technology contract awarded to NeoLight for Skylife Neonatal Phototherapy System. Vizient represents academic medical centers, pediatric facilities, community hospitals, and integrated health delivery networks representing more than $130 billion in annual purchasing volume.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2021-11-30
Description

NeoLight acquired Phoenix Technology Group LLC, a provider of advanced ophthalmic imaging devices including Phoenix ICON, Phoenix ICON GO, and Phoenix CONNECT telemedicine platform. This acquisition expanded NeoLight's product portfolio to include ocular imaging and expanded global reach through PTG's distribution network in 95+ countries.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Natus Medical is a direct competitor in neonatal care devices, offering phototherapy (neoBLUE), brain monitoring (Olympic CFM), and hearing screening products that overlap directly with NeoLight's Skylife and nëo CFM lines, sold to the same NICU customer base.

2Drägerwerk
TypeDirect peer
Description

Dräger offers the Bililux phototherapy lamp, neonatal incubators, and transport systems that compete with NeoLight's Skylife phototherapy and BABYPOD/NEOPOD infant transport products in the same hospital NICU market.

TypeBroad incumbent
Description

GE Healthcare is a broad incumbent offering BiliBlanket phototherapy, Giraffe warmers, and other neonatal care equipment that compete with NeoLight's products as part of a much wider hospital portfolio, with substantially greater resources and global reach.

TypeBroad incumbent
Description

Philips is a broad incumbent in patient monitoring and neonatal care (including BiliTx phototherapy), competing with NeoLight across multiple categories as part of a large integrated healthcare portfolio.

TypeDirect peer
Description

Masimo competes in neonatal patient monitoring and brain monitoring technologies, overlapping with NeoLight's nëo CFM aEEG brain monitoring product line for neonatal care decision-making.

TypeDirect peer
Description

Nidek's RetCam retinal imaging system is the most established competitor to NeoLight's Phoenix ICON and ICON GO for pediatric and neonatal ROP screening, serving the same ophthalmology and neonatology hospital customers.

TypeBroad incumbent
Description

CooperSurgical serves women's and neonatal health markets with products spanning fertility, obstetrics, and newborn care, and overlaps with NeoLight's neonatal medical device portfolio as part of a broader women's health platform.

TypeEmerging player
Description

International Biomedical manufactures neonatal transport incubators and infant care equipment that compete with NeoLight's BABYPOD, NEOPOD, and SCANPOD transport product line in the same hospital transport market.

TypeEmerging player
Description

Clarity Medical Systems offers pediatric retinal imaging systems for ROP screening that overlap with NeoLight's Phoenix ICON retinal imaging platform, targeting the same NICU and ophthalmology customers.

TypeBroad incumbent
Description

Medtronic is a broad incumbent medical device company whose patient monitoring and respiratory products overlap with NeoLight's brain monitoring and neonatal respiratory-support adjacencies in hospital ICU settings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NeoLight

Neonatal Medical Devicestheneolight.com

NeoLight is a Scottsdale-based medical device company developing neonatal care technologies including phototherapy (Skylife), retinal imaging (Phoenix ICON), brain monitoring (néo CFM), and transport devices, serving hospitals, NICUs, and home healthcare markets across 95+ countries.

What NeoLight does

NeoLight is a Scottsdale, Arizona-based medical device company founded in 2014 that develops a portfolio of neonatal care technologies organized across five product categories: ocular screening (Phoenix ICON, Phoenix ICON GO, and Phoenix CONNECT telemedicine platform), jaundice treatment (Skylife phototherapy system), brain monitoring (néo CFM with aEEG), non-nutritive sucking therapy (P.A.L. Pacifier Activated Lullaby), and neonatal transport/thermoregulation (NEOPOD, BABYPOD series, SCANPOD, BP37). Core technologies include patented Direct Illumination retinal imaging, Skylife's 3D Light Array providing 40% body surface coverage, and the Phoenix CONNECT cloud-based telemedicine platform that connects nursing, ophthalmology, and neonatology teams for remote expert screening.

The company serves hospitals, NICUs, ophthalmology departments, and home healthcare settings, with claimed reach into 90% of America's top children's hospitals and distribution in more than 95 countries. Its go-to-market combines direct enterprise sales in the US and Canada with GPO contracts (Vizient, Capstone Health Alliance, Premier KIINDO) for hospital network access and international distribution partners for global markets. Revenue is generated through capital medical device hardware sales, with the Phoenix CONNECT platform providing potential recurring software revenue. Strategic acquisitions have been central to portfolio expansion, including Phoenix Technology Group (Nov 2021) for ophthalmic imaging and P.A.L. musical pacifier technology (Oct 2022), with an announced agreement to acquire InterVIEW Medical Systems (April 2023).

NeoLight has raised approximately $18.4 million across eight funding rounds from 2015-2022, with the largest disclosed round being $7 million in August 2020 from Dignity Health, Honor Health, and the Roethlisberger family. The company holds multiple FDA 510(k) clearances and issued US patents, and is led by co-founder and CEO Vivek Kopparthi alongside a management team including CCO MaryBeth Smith, CFO Ronald Wysochansky, and co-founder Deepak Krishnaraju, with a board that includes former Stryker executive Jim Heath and other medical device veterans.

NeoLight firmographics

Firmographics
Name
NeoLight
Legal name
NeoLight LLC
Website
https://theneolight.com
Company type
Private
Founded year
2014
Headcount range
11–50 employees
Short description
NeoLight is a Scottsdale-based medical device company developing neonatal care technologies including phototherapy (Skylife), retinal imaging (Phoenix ICON), brain monitoring (néo CFM), and transport devices, serving hospitals, NICUs, and home healthcare markets across 95+ countries.
Ownership category
akta.pro rank

NeoLight industry classification

Industry
Product category
Neonatal Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACAFAC
Maternal & Neonatal Remote Monitoring Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • Neonatal medical devices
  • Phototherapy systems
  • Retinal imaging devices
  • Brain monitoring equipment
  • Neonatal transport equipment

Where NeoLight is headquartered

Location

Headquarters

HQ city
Scottsdale
HQ country
United States
HQ region
North America

Offices2 records

Markets served

NeoLight business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Hardware Sales: NeoLight generates revenue through the sale of capital medical equipment including Skylife Neonatal Phototherapy System, Phoenix ICON ophthalmic imaging systems, nëo CFM brain monitoring devices, and P.A.L. non-nutritive sucking devices. Products are sold to hospitals, clinics, and healthcare providers for neonatal care.
  2. Phoenix CONNECT Software Platform: Cloud-based telemedicine platform for ophthalmic screening is offered as part of the product ecosystem, potentially generating recurring revenue through software subscriptions and services.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

NeoLight product offering

Product offering

Core offering

NeoLight designs, manufactures, and sells a portfolio of proprietary neonatal medical devices for hospitals and NICUs, organized across ocular screening (Phoenix ICON retinal imaging systems and Phoenix CONNECT telemedicine platform), jaundice care (Skylife phototherapy), brain monitoring (nëo CFM aEEG), non-nutritive sucking therapy (P.A.L.), and neonatal transport (NEOPOD, BABYPOD series, SCANPOD, BP37). The company sells capital equipment through direct sales in the US/Canada and via international distribution partners across 95+ countries, supplemented by GPO contracts and recurring software subscriptions.

Product overview

NeoLight is a medical device company offering a portfolio of empathy-driven neonatal care technologies organized across five product categories: (1) Ocular Screening via the Phoenix ICON platform family (Phoenix ICON desktop retinal imaging, Phoenix ICON GO portable imaging, and Phoenix CONNECT telemedicine platform); (2) Jaundice Care through the Skylife Neonatal Phototherapy System with best-in-class spectral power; (3) Brain Monitoring via the nëo CFM aEEG system; (4) Non-Nutritive Sucking through P.A.L. technology; and (5) Neonatal Transport including NEOPOD, BABYPOD series, SCANPOD, and BP37 thermal accessories. The company operates a platform-plus-products architecture, with Phoenix CONNECT serving as a cloud-based telemedicine hub connecting the various imaging and screening products across hospital networks.

Differentiator

Problem solved

Functional benefit

Products and services

  • Phoenix ICON Retinal imaging system with patented Direct Illumination technology delivering superior high-resolution, high-contrast imaging on both light and dark retinas; sold direct in US/Canada and via distribution partners in 95+ countries for neonatal and pediatric ophthalmic screening.
  • Phoenix ICON GO Lightweight, portable retinal imaging system capable of supporting large remote networks and inter-hospital subspecialties; FDA 510(k) cleared with expanded fluorescein angiography capabilities for neonatal and pediatric use.
  • Phoenix CONNECT Cloud-based telemedicine communication platform for retinal imaging programs that connects nursing, ophthalmology, and neonatology teams to enable timely expert screening of babies in any NICU.
  • Skylife Neonatal Phototherapy System Neonatal Phototherapy System with best-in-class spectral power and 3D Light Array providing 40% body surface coverage with effective, uniform light; FDA cleared for hospital and home use to treat hyperbilirubinemia.
  • nëo CFM Brain Monitoring System Advanced brain monitoring system with aEEG (amplitude-integrated electroencephalography) for accelerated decision-making during neonatal care; exclusive USA partnership with ANT Neuro.
  • P.A.L. (Pacifier Activated Lullaby) Therapeutic system that encourages and reinforces effective non-nutritive sucking of premature infants through positive audio feedback using parents' voices to promote progression of oral feeding.
  • NEOPOD Safe, secure newborn baby transport system for neonatal and pediatric transport.
  • BABYPOD 2 Infant transport device designed for safe neonatal transport with thermal regulation features.
  • BABYPOD 20 Next-generation infant transport device with design advances for improved neonatal transport safety and functionality.
  • SCANPOD Specialized transport pod designed for MRI, CT, or X-Ray imaging of infants.
  • BP37 Thermal Support Kit Infant temperature maintenance kit providing thermal support accessory for Babypod transport systems.
  • P.A.L. Music Service Service that empowers neonatal care with the sound of parents' voices, extending the P.A.L. therapeutic platform.

Quantifiable outcome

  • 40% body surface coverage with Skylife 3D Light Array
  • +4 more outcomes

Companies that use NeoLight

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

NeoLight technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

NeoLight partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered minor and core.

  • Advanced Healthcare TechnologyminorStrategic or Co-development Partner · 28 January 2026Strategic partnership for continued expansion of the neonatal ecosystem, announced January 2026.
  • Premier, Inc.coreChannel Partner/ Reseller/ Distributor · 27 November 2024KIINDO breakthrough technology agreement providing Premier members access to NeoLight's Skylife systems. Premier is the nation's largest member-driven healthcare performance improvement company.
  • ANT NeurocoreStrategic or Co-development Partner · 8 July 2024Exclusive USA partnership for the nëo CFM brain monitoring system. ANT Neuro provides EEG/aEEG technology expertise while NeoLight distributes and commercializes the system in the US market.
  • Capstone Health AlliancecoreChannel Partner/ Reseller/ Distributor · 1 February 2024GPO contract with Capstone Health Alliance for Skylife Neonatal Phototherapy System, providing access to member hospitals.
  • Florida State UniversitycoreStrategic or Co-development Partner · 26 September 2023Partnership with Florida State University's National Institute for Infant and Child Medical Music Therapy to extend P.A.L. technology application. FSU provides research and clinical expertise in music therapy for premature infants while NeoLight provides the technological platform.
  • InterVIEW Medical SystemsminorOEM/ Whitelabel/ Licensing Partner · 25 April 2023Agreement to acquire InterVIEW Medical Systems, a globally recognized provider of ROP education and examination content.
  • Vizient, Inc.coreChannel Partner/ Reseller/ Distributor · 6 September 2022Innovative Technology contract awarded to NeoLight for Skylife Neonatal Phototherapy System. Vizient represents academic medical centers, pediatric facilities, community hospitals, and integrated health delivery networks representing more than $130 billion in annual purchasing volume.
  • Phoenix Technology Group LLCcoreOEM/ Whitelabel/ Licensing Partner · 30 November 2021NeoLight acquired Phoenix Technology Group LLC, a provider of advanced ophthalmic imaging devices including Phoenix ICON, Phoenix ICON GO, and Phoenix CONNECT telemedicine platform. This acquisition expanded NeoLight's product portfolio to include ocular imaging and expanded global reach through PTG's distribution network in 95+ countries.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

NeoLight competitors and assessment

Company assessment

Direct peers

  • Natus Medical: Natus Medical is a direct competitor in neonatal care devices, offering phototherapy (neoBLUE), brain monitoring (Olympic CFM), and hearing screening products that overlap directly with NeoLight's Skylife and nëo CFM lines, sold to the same NICU customer base.
  • Drägerwerk: Dräger offers the Bililux phototherapy lamp, neonatal incubators, and transport systems that compete with NeoLight's Skylife phototherapy and BABYPOD/NEOPOD infant transport products in the same hospital NICU market.
  • Masimo: Masimo competes in neonatal patient monitoring and brain monitoring technologies, overlapping with NeoLight's nëo CFM aEEG brain monitoring product line for neonatal care decision-making.
  • Nidek: Nidek's RetCam retinal imaging system is the most established competitor to NeoLight's Phoenix ICON and ICON GO for pediatric and neonatal ROP screening, serving the same ophthalmology and neonatology hospital customers.

Broad incumbents

  • GE Healthcare: GE Healthcare is a broad incumbent offering BiliBlanket phototherapy, Giraffe warmers, and other neonatal care equipment that compete with NeoLight's products as part of a much wider hospital portfolio, with substantially greater resources and global reach.
  • Philips Healthcare: Philips is a broad incumbent in patient monitoring and neonatal care (including BiliTx phototherapy), competing with NeoLight across multiple categories as part of a large integrated healthcare portfolio.
  • CooperSurgical: CooperSurgical serves women's and neonatal health markets with products spanning fertility, obstetrics, and newborn care, and overlaps with NeoLight's neonatal medical device portfolio as part of a broader women's health platform.
  • Medtronic: Medtronic is a broad incumbent medical device company whose patient monitoring and respiratory products overlap with NeoLight's brain monitoring and neonatal respiratory-support adjacencies in hospital ICU settings.

Emerging players

  • International Biomedical: International Biomedical manufactures neonatal transport incubators and infant care equipment that compete with NeoLight's BABYPOD, NEOPOD, and SCANPOD transport product line in the same hospital transport market.
  • Clarity Medical Systems: Clarity Medical Systems offers pediatric retinal imaging systems for ROP screening that overlap with NeoLight's Phoenix ICON retinal imaging platform, targeting the same NICU and ophthalmology customers.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

NeoLight social profiles

Digital presence

NeoLight financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NeoLight leadership team

Management profile

Number of profiles

Profiles17 records

NeoLight subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

NeoLight funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NeoLight M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NeoLight

What does NeoLight do?

NeoLight designs, manufactures, and sells a portfolio of proprietary neonatal medical devices for hospitals and NICUs, organized across ocular screening (Phoenix ICON retinal imaging systems and Phoenix CONNECT telemedicine platform), jaundice care (Skylife phototherapy), brain monitoring (nëo CFM aEEG), non-nutritive sucking therapy (P.A.L.), and neonatal transport (NEOPOD, BABYPOD series, SCANPOD, BP37). The company sells capital equipment through direct sales in the US/Canada and via international distribution partners across 95+ countries, supplemented by GPO contracts and recurring software subscriptions.

Is NeoLight a public or private company?

NeoLight is a private company. It is classified as venture growth investor backed.

When was NeoLight founded?

NeoLight was founded in 2014. It employs 11 to 50 people.

Where is NeoLight based?

NeoLight is headquartered in Scottsdale, United States, in the North America region.

How does NeoLight make money?

Two revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are phoenix CONNECT Software Platform.

Who are NeoLight's main competitors?

Direct peers on record are Natus Medical, Drägerwerk, Masimo and Nidek. Broad incumbents are GE Healthcare, Philips Healthcare, CooperSurgical and Medtronic. Emerging players are International Biomedical and Clarity Medical Systems.

Does NeoLight have an API?

No public API is recorded for NeoLight.

What industry is NeoLight in?

NeoLight's product category is Neonatal Medical Devices. Its primary akta.pro industry code is HLACAFAC, Maternal & Neonatal Remote Monitoring Platforms. Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comNewborn Eye Imaging Systems Market Overview, Key Trends, and Major Player AnalysisThe global newborn eye imaging systems market is projected to reach $3.19 billion by 2030, growing at a CAGR of 7.8%, driven by rising investments in neonatal screening programs and increased adoption of AI-driven diagnostic imaging tools. India-based Forus Health partnered with Google in October 2024 to integrate Google's AI model for diabetic retinopathy screening into Forus's retinal imaging platform. US-based NeoLight LLC received FDA 510(k) clearance in September 2023 for ICON GO, a portable fluorescein angiography-enabled retinal imaging system for neonatal and pediatric use.PR NewswireSeasoned Healthcare Leader David Myers Joins NeoLight as Strategic AdvisorNeoLight, a provider of empathy-driven medical devices for newborn care, announced the appointment of David Myers as Strategic Advisor. Myers brings over two decades of healthcare leadership experience, having previously served as SVP & Chief Procurement Officer at Owens & Minor and as President & COO at Seneca Medical (later Concordance Healthcare Solutions), along with senior roles at Baxter International, AMSCO International, and STERIS Corporation. The appointment is intended to accelerate adoption of NeoLight's neonatal care solutions and support the company's continued growth and innovation in the healthcare sector.PR NewswireKen Reali, Renowned Healthcare Executive, Joins NeoLight's Board of DirectorsNeoLight announced the appointment of Ken Reali, a healthcare executive with over 30 years in the medical device sector, to its Board of Directors. Reali previously served as CEO of Bioventus and led Clinical Innovations before its successful sale in 2020. The appointment is intended to strengthen NeoLight's board expertise in product development, global marketing, and commercialization as the company expands in neonatal care technology.PR NewswireNeoLight reaches agreement to acquire InterVIEW Medical Systems, globally recognized provider of ROP education and examinationNeoLight agreed to acquire InterVIEW Medical Systems, a provider of ROP education and examination. The company's ROP Certificate Program is recognized by OMIC and the American Academy of Ophthalmology, and has served over 60% of U.S. pediatric ophthalmologists and retina specialists. NeoLight will continue working with InterVIEW's founding physicians to improve the program.PR NewswireNeoLight launches ROP risk management software ROPCheck.com, expanding leadership in the pediatric ophthalmology spaceNeoLight announced the launch of ROP Check, a SaaS platform for digital care coordination in pediatric retinal screening to detect and monitor retinopathy of prematurity in premature infants. The software enables cross-functional management of patients, NICUs, ophthalmology specialists, and billing across inpatient and outpatient settings. The launch follows NeoLight's 2021 acquisition of Phoenix Technology Group, which brought newborn eye screening into its portfolio, as the company builds a connected digital ecosystem to eliminate ROP blindness worldwide.PR NewswireNeoLight acquires first-of-its-kind musical pacifier technology for premature babiesNeoLight has signed an agreement to acquire the Pacifier Activated Lullaby (PAL) System from Powers Medical Inc., a US-based medical technology company. This acquisition adds a musical pacifier technology designed to treat non-nutritive sucking and Neonatal Abstinence Syndrome in premature infants to NeoLight's neonatal portfolio. The deal allows NeoLight to expand the deployment of the PAL system, which clinical trials have shown to reduce hospital stays and improve feeding outcomes, to its global network of hospitals.SecSEC FORM DNeoLight, LLC filed a Form D with the Securities and Exchange Commission to report an exempt securities offering under Rule 506(b). The filing indicates that the company has sold $2,819,951 of equity securities out of a total offering amount of $4,000,000 to nine investors. The primary place of business for this Arizona-based entity is located in Phoenix.PR NewswireNeoLight Acquires Occular Screening Leader Phoenix Technology Group, Strengthening the Company's Newborn Care Global StrategyNeoLight LLC has acquired Phoenix Technology Group LLC, a provider of advanced ophthalmic imaging devices and telemedicine platforms for retinopathy of prematurity screening, strengthening NeoLight's newborn care portfolio. The acquisition adds Phoenix ICON and Phoenix CONNECT products, which are currently sold in over 95 countries worldwide. NeoLight plans to leverage PTG's global distribution network to expand its Skylife Neonatal Phototherapy System internationally.PR NewswireNeoLight LLC. Selected to Exhibit Skylife at Vizient Innovative Technology ExchangeNeoLight LLC has been selected to exhibit its Skylife Neonatal Phototherapy System at the Vizient Innovative Technology Exchange, to be held virtually September 21-23, 2021. Vizient, the nation's largest member-driven health care performance improvement company, invites selected suppliers to demonstrate technologies to supply chain and clinical leaders from its member hospitals. The Exchange is part of Vizient's Innovative Technology Program, which can result in contracts for qualified products.TechCrunchNeoLight’s jaundice treatment catches another $7 million to bring neonatal light therapy to the homeNeoLight, a startup developing hospital-grade neonatal care technologies for home use, has raised an additional $7 million in financing with participation from Dignity Health and Honor Health Systems, along with existing investors including Ben and Ashley Roethlisberger. The company pivoted its light therapy devices, designed to treat jaundice in newborns, from hospital settings to home use as hospitals began discharging newborns earlier due to COVID-19 quarantine protocols. Jaundice affects roughly 60% of newborns and can cause brain damage if left untreated.